Marta Kania-Pudło
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marta Kania-Pudło has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Arkadiusz Zegadło
Clinical Department of Radiology, Military Institute of Medicine—National Research Institute, 04-141 Warsaw, Poland
2 shared publications - Artur Maliborski
Department of Radiology, Military Institute of Medicine, 04-141 Warsaw, Poland
2 shared publications - Magdalena Żabicka
Department of Radiology, Military Institute of Medicine—National Research Institute, Szaserów 128, 04-141 Warsaw, Poland
2 shared publications - Adrianna Niksińska
Department of Internal Medicine and Rheumatology, Military Institute of Medicine, National Research Institute, Warsaw, Poland
1 shared publication - Aleksandra Różyk
Department of Radiology, Military Institute of Medicine, Szaserow 128, 04-141 Warsaw, Poland
1 shared publication - Andrzej Chciałowski
Department of Internal Medicine, Infectious Diseases and Allergology, Military Institute of Medicine–National Research Institute, 04-141 Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 30 May 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (6) , 120
Comparable effectiveness of intensive intravenous and less intensive immunosuppressive treatment in retroperitoneal fibrosis: a retrospective real-world cohort study
Retroperitoneal fibrosis (RPF) is a rare fibro-inflammatory disease frequently complicated by ureteral obstruction and renal impairment. Due to its rarity, heterogeneous clinical course, and the absence of standardized treatment guidelines, optimal immunosuppressive management of RPF remains uncertain. This study aimed to evaluate the real-world effectiveness and safety of different immunosuppressive treatment strategies in patients with RPF. A retrospective, single-center observational study was conducted including patients with idiopathic or immune-mediated RPF treated between 2010 and 2025. Patients were grouped according to treatment strategy: intensive intravenous therapy with cyclophosphamide or rituximab, or less intensive oral immunosuppressive therapy including methotrexate, mycophenolate mofetil or azathioprine. Treatment effectiveness was assessed using a composite endpoint incorporating clinical, laboratory and radiological response. Secondary outcomes included renal function, relapse, treatment safety, and glucocorticoid exposure. Twenty-nine patients were included in the analysis, of whom 11 received intensive therapy and 18 were treated with less intensive oral immunosuppressive regimens. Overall treatment effectiveness was achieved in 68% of evaluable patients and did not differ significantly between groups (OR 2.67, 95% CI 0.41–17.17). Clinical, laboratory, and radiological responses did not differ significantly between treatment groups. Hydronephrosis resolved in 75% of affected patients. Median serum creatinine levels improved during follow-up in both treatment groups, without significant intergroup differences at last observation (1.20 mg/dL [1.10–1.30] vs. 1.20 mg/dL [0.80–1.40]). The median relative reduction in periaortic mass thickness was 41.2% (24.45–53.95). No significant differences in overall safety outcomes were observed. In this real-world cohort of patients with RPF, intensive intravenous immunosuppressive regimens were not associated with superior treatment effectiveness compared with less intensive oral therapies. These findings support an individualized approach to treatment selection in RPF, taking disease severity, renal involvement and patient-specific factors into account. Prospective studies in larger cohorts are needed to further define optimal long-term management strategies for this rare disease.
- 30 May 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (6) , 120
Open AccessComparable effectiveness of intensive intravenous and less intensive immunosuppressive treatment in retroperitoneal fibrosis: a retrospective real-world cohort study
Retroperitoneal fibrosis (RPF) is a rare fibro-inflammatory disease frequently complicated by ureteral obstruction and renal impairment. Due to its rarity, heterogeneous clinical course, and the absence of standardized treatment guidelines, optimal immunosuppressive management of RPF remains uncertain. This study aimed to evaluate the real-world effectiveness and safety of different immunosuppressive treatment strategies in patients with RPF. A retrospective, single-center observational study was conducted including patients with idiopathic or immune-mediated RPF treated between 2010 and 2025. Patients were grouped according to treatment strategy: intensive intravenous therapy with cyclophosphamide or rituximab, or less intensive oral immunosuppressive therapy including methotrexate, mycophenolate mofetil or azathioprine. Treatment effectiveness was assessed using a composite endpoint incorporating clinical, laboratory and radiological response. Secondary outcomes included renal function, relapse, treatment safety, and glucocorticoid exposure. Twenty-nine patients were included in the analysis, of whom 11 received intensive therapy and 18 were treated with less intensive oral immunosuppressive regimens. Overall treatment effectiveness was achieved in 68% of evaluable patients and did not differ significantly between groups (OR 2.67, 95% CI 0.41–17.17). Clinical, laboratory, and radiological responses did not differ significantly between treatment groups. Hydronephrosis resolved in 75% of affected patients. Median serum creatinine levels improved during follow-up in both treatment groups, without significant intergroup differences at last observation (1.20 mg/dL [1.10–1.30] vs. 1.20 mg/dL [0.80–1.40]). The median relative reduction in periaortic mass thickness was 41.2% (24.45–53.95). No significant differences in overall safety outcomes were observed. In this real-world cohort of patients with RPF, intensive intravenous immunosuppressive regimens were not associated with superior treatment effectiveness compared with less intensive oral therapies. These findings support an individualized approach to treatment selection in RPF, taking disease severity, renal involvement and patient-specific factors into account. Prospective studies in larger cohorts are needed to further define optimal long-term management strategies for this rare disease.
- Open Access
- 24 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6756
A Retrospective Study of the Prevalence of Maxillary Sinus Cysts Incidentally Detected on MRI Among Non-Symptomatic Caucasian Population
Maxillary sinus abnormalities, including retention cysts and mucosal thickening, are often incidental findings and may be present in up to 35.6%, depending on imaging modality and population characteristics. To date, few studies have explored the appearance of maxillary sinus retention cysts using MRI. Aim: This study provides the first large-scale MRI-based assessment of these lesions, with the aim of evaluating the prevalence and characteristics of maxillary sinus abnormalities detected incidentally on head MRI scans, particularly focusing on retention cysts and mucosal changes. Materials and Methods: A retrospective analysis of 3092 head MRI scans obtained between 2023 and 2024 was conducted to assess the prevalence and characteristics of maxillary sinus abnormalities. The mean patient age was 54.5 ± 18.6 years (median 56; range 18–99 years), with 1,825 women (59%). Statistical power exceeded 83% to detect differences of at least 10% in the prevalence of cysts between age groups (α = 0.05). A simplified MRI-based sinus assessment scale was used to categorize findings. Results: Out of 3092 scans, 1995 (64.5%) showed normal sinuses, 817 (26.4%) had mucosal thickening < 5 mm, 116 (3.8%) presented with retention cysts without other pathology, 100 (3.2%) exhibited moderate changes, and 64 (2.1%) had severe changes. Cysts were significantly more frequent in men (7.5%) than in women (4.4%) (p < 0.001). Additionally, maxillary sinus involvement differed significantly between sexes, with a higher prevalence in men. Conclusions: Incidental maxillary sinus findings are common and often benign. A comprehensive diagnostic approach is essential, especially for unilateral lesions near tooth roots. Conservative management remains appropriate for asymptomatic patients, but ongoing monitoring and patient education are key to preventing complications.
- 24 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6756
Open AccessA Retrospective Study of the Prevalence of Maxillary Sinus Cysts Incidentally Detected on MRI Among Non-Symptomatic Caucasian Population
Maxillary sinus abnormalities, including retention cysts and mucosal thickening, are often incidental findings and may be present in up to 35.6%, depending on imaging modality and population characteristics. To date, few studies have explored the appearance of maxillary sinus retention cysts using MRI. Aim: This study provides the first large-scale MRI-based assessment of these lesions, with the aim of evaluating the prevalence and characteristics of maxillary sinus abnormalities detected incidentally on head MRI scans, particularly focusing on retention cysts and mucosal changes. Materials and Methods: A retrospective analysis of 3092 head MRI scans obtained between 2023 and 2024 was conducted to assess the prevalence and characteristics of maxillary sinus abnormalities. The mean patient age was 54.5 ± 18.6 years (median 56; range 18–99 years), with 1,825 women (59%). Statistical power exceeded 83% to detect differences of at least 10% in the prevalence of cysts between age groups (α = 0.05). A simplified MRI-based sinus assessment scale was used to categorize findings. Results: Out of 3092 scans, 1995 (64.5%) showed normal sinuses, 817 (26.4%) had mucosal thickening < 5 mm, 116 (3.8%) presented with retention cysts without other pathology, 100 (3.2%) exhibited moderate changes, and 64 (2.1%) had severe changes. Cysts were significantly more frequent in men (7.5%) than in women (4.4%) (p < 0.001). Additionally, maxillary sinus involvement differed significantly between sexes, with a higher prevalence in men. Conclusions: Incidental maxillary sinus findings are common and often benign. A comprehensive diagnostic approach is essential, especially for unilateral lesions near tooth roots. Conservative management remains appropriate for asymptomatic patients, but ongoing monitoring and patient education are key to preventing complications.
- Open Access
- 7 May 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (10) , 2733
Pulmonary Function, Computed Tomography Lung Abnormalities, and Small Airway Disease after COVID-19: 3-, 6-, and 9-Month Follow-Up
Background/Objectives: Coronavirus disease 2019 (COVID-19) course may differ among individuals—in particular, those with comorbidities may have severe pneumonia, requiring oxygen supplementation or mechanical ventilation. Post-COVID-19 long-term structural changes in imaging studies can contribute to persistent respiratory disturbance. This study aimed to investigate COVID-19 sequels affecting the possibility of persistent structural lung tissue abnormalities and their influence on the respiratory function of peripheral airways and gas transfer. Methods: Patients were divided into two groups according to severity grades described by the World Health Organization. Among the 176 hospitalized patients were 154 patients with mask oxygen supplementation and 22 patients with high-flow nasal cannula (HFNC) or mechanical ventilation. All tests were performed at 3, 6, and 9 months post-hospitalization. Results: Patients in the severe/critical group had lower lung volumes in FVC, FVC%, FEV1, FEV1%, LC, TLC%, and DLCO% at three months post-hospitalization. At 6 and 9 months, neither group had significant FVC and FEV1 value improvements. The MEF 25–75 values were not significantly higher in the mild/moderate group than in the severe/critical group at three months. There were weak significant correlations between FVC and FEV1, MEF50, MEF 75, plethysmography TLC, disturbances in DLCO, and total CT abnormalities in the severe/critical group at three months. In a mild/moderate group, there was a significant negative correlation between the spirometry, plethysmography parameters, and CT lesions in all periods. Conclusions: Persistent respiratory symptoms post-COVID-19 can result from fibrotic lung parenchyma and post-infectious stenotic small airway changes not visible in CT, probably due to persistent inflammation.
- 7 May 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (10) , 2733
Open AccessPulmonary Function, Computed Tomography Lung Abnormalities, and Small Airway Disease after COVID-19: 3-, 6-, and 9-Month Follow-Up
Background/Objectives: Coronavirus disease 2019 (COVID-19) course may differ among individuals—in particular, those with comorbidities may have severe pneumonia, requiring oxygen supplementation or mechanical ventilation. Post-COVID-19 long-term structural changes in imaging studies can contribute to persistent respiratory disturbance. This study aimed to investigate COVID-19 sequels affecting the possibility of persistent structural lung tissue abnormalities and their influence on the respiratory function of peripheral airways and gas transfer. Methods: Patients were divided into two groups according to severity grades described by the World Health Organization. Among the 176 hospitalized patients were 154 patients with mask oxygen supplementation and 22 patients with high-flow nasal cannula (HFNC) or mechanical ventilation. All tests were performed at 3, 6, and 9 months post-hospitalization. Results: Patients in the severe/critical group had lower lung volumes in FVC, FVC%, FEV1, FEV1%, LC, TLC%, and DLCO% at three months post-hospitalization. At 6 and 9 months, neither group had significant FVC and FEV1 value improvements. The MEF 25–75 values were not significantly higher in the mild/moderate group than in the severe/critical group at three months. There were weak significant correlations between FVC and FEV1, MEF50, MEF 75, plethysmography TLC, disturbances in DLCO, and total CT abnormalities in the severe/critical group at three months. In a mild/moderate group, there was a significant negative correlation between the spirometry, plethysmography parameters, and CT lesions in all periods. Conclusions: Persistent respiratory symptoms post-COVID-19 can result from fibrotic lung parenchyma and post-infectious stenotic small airway changes not visible in CT, probably due to persistent inflammation.
- Open Access
- 4 August 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (8) , 2514
Assessment of Solitary Pulmonary Nodules Based on Virtual Monochrome Images and Iodine-Dependent Images Using a Single-Source Dual-Energy CT with Fast kVp Switching
With lung cancer being the most common malignancy diagnosed worldwide, lung nodule assessment has proved to be one of big challenges of modern medicine. The aim of this study was to examine the usefulness of Dual Energy Computed Tomography (DECT) in solitary pulmonary nodule (SPN) assessment. Between January 2017 and June 2018; 65 patients (42 males and 23 females) underwent DECT scans in the late arterial phase (AP) and venous phase (VP). We concluded that imaging at an energy level of 65 keV was the most accurate in detecting malignancy in solitary pulmonary nodules (SPNs) measuring ≤30 mm in diameter on virtual monochromatic maps. Both virtual monochromatic images and iodine concentration maps prove to be highly useful in differentiating benign and malignant pulmonary nodules. As for iodine concentration maps, the analysis of venous phase images resulted in the highest clinical usefulness. To summarize, DECT may be a useful tool in the differentiation of benign and malignant SPNs. A single-phase DECT examination with scans acquired 90 s after contrast media injection is recommended.
- 4 August 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (8) , 2514
Open AccessAssessment of Solitary Pulmonary Nodules Based on Virtual Monochrome Images and Iodine-Dependent Images Using a Single-Source Dual-Energy CT with Fast kVp Switching
With lung cancer being the most common malignancy diagnosed worldwide, lung nodule assessment has proved to be one of big challenges of modern medicine. The aim of this study was to examine the usefulness of Dual Energy Computed Tomography (DECT) in solitary pulmonary nodule (SPN) assessment. Between January 2017 and June 2018; 65 patients (42 males and 23 females) underwent DECT scans in the late arterial phase (AP) and venous phase (VP). We concluded that imaging at an energy level of 65 keV was the most accurate in detecting malignancy in solitary pulmonary nodules (SPNs) measuring ≤30 mm in diameter on virtual monochromatic maps. Both virtual monochromatic images and iodine concentration maps prove to be highly useful in differentiating benign and malignant pulmonary nodules. As for iodine concentration maps, the analysis of venous phase images resulted in the highest clinical usefulness. To summarize, DECT may be a useful tool in the differentiation of benign and malignant SPNs. A single-phase DECT examination with scans acquired 90 s after contrast media injection is recommended.